Reports suggest that de-extinction startup Colossal Biosciences is in talks to raise fresh capital at a valuation between $20 billion and $30 billion, potentially doubling or tripling its prior worth. This kind of jump is a striking example of current startup valuation trends, where ambitious science and bold storytelling continue to attract enormous investor interest. For small business owners, the headline number matters less than what it reveals about where money is flowing and why.
Try Pigee e-Signature: https://social.pigeepost.com/pigee-esignature
Originally reported by techcrunch.com.